HarborSite

HarborSite

Research-stage platform for inserting therapeutic genes into safe genomic sites with engineered recombinases

harborsite.com

Industry
Biotech
Based in
United States

Verified revenue: not connected yet

Is HarborSite yours? Claim this page and connect Stripe, the App Store or Google Play: your MRR and growth show here, read straight from the source.

Claim it if it’s yours

About

HarborSite is a Harvard/Wyss Institute spinoff developing engineered recombinase enzymes to insert full-length therapeutic genes into safe sites in the genome, aiming at one-time treatments for genetic and age-related diseases. It is at research stage, with an initial focus on liver and blood cells. It is based in Boston, US, and is backed by Armenia-based SmartGate VC.

Team

  • Erik Aznauryan, Co-founder and CEO (Founder)
  • George Church, Co-founder and Scientific Advisory Board Chair (Founder)
  • Tina Lebar, Co-founder and Scientific Advisory Board Member (Founder)

Audience

Followers on social networks

Profile data from Stanbase.